CORSICO, ANGELO GUIDO
 Distribuzione geografica
Continente #
NA - Nord America 6.585
AS - Asia 4.772
EU - Europa 4.409
SA - Sud America 805
AF - Africa 66
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 16.649
Nazione #
US - Stati Uniti d'America 6.448
CN - Cina 2.636
SG - Singapore 982
IE - Irlanda 944
BR - Brasile 663
HK - Hong Kong 629
RU - Federazione Russa 577
IT - Italia 568
DE - Germania 559
UA - Ucraina 493
FI - Finlandia 471
VN - Vietnam 247
GB - Regno Unito 210
SE - Svezia 197
FR - Francia 145
IN - India 83
CA - Canada 79
AR - Argentina 59
PL - Polonia 43
MX - Messico 38
BE - Belgio 34
JP - Giappone 34
NL - Olanda 34
AT - Austria 32
ZA - Sudafrica 29
EC - Ecuador 28
BD - Bangladesh 23
ES - Italia 23
CZ - Repubblica Ceca 20
ID - Indonesia 18
TR - Turchia 17
LT - Lituania 15
CL - Cile 12
IQ - Iraq 12
SA - Arabia Saudita 11
CO - Colombia 10
PY - Paraguay 10
IL - Israele 8
PE - Perù 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
MU - Mauritius 7
TN - Tunisia 7
UZ - Uzbekistan 7
JO - Giordania 6
MA - Marocco 6
PH - Filippine 6
PK - Pakistan 6
AU - Australia 5
CH - Svizzera 5
DK - Danimarca 5
EG - Egitto 5
JM - Giamaica 5
RO - Romania 5
SK - Slovacchia (Repubblica Slovacca) 5
GR - Grecia 4
KE - Kenya 4
KZ - Kazakistan 4
LB - Libano 4
UY - Uruguay 4
AZ - Azerbaigian 3
BY - Bielorussia 3
DZ - Algeria 3
HU - Ungheria 3
IR - Iran 3
LK - Sri Lanka 3
NP - Nepal 3
OM - Oman 3
PA - Panama 3
AL - Albania 2
AM - Armenia 2
BB - Barbados 2
BG - Bulgaria 2
BO - Bolivia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
EU - Europa 2
KG - Kirghizistan 2
MK - Macedonia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PT - Portogallo 2
TH - Thailandia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
DM - Dominica 1
EE - Estonia 1
GH - Ghana 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
KH - Cambogia 1
KR - Corea 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 16.639
Città #
Chandler 951
Dublin 943
Dallas 647
Hong Kong 623
Jacksonville 610
Nanjing 564
Ashburn 517
Beijing 478
Singapore 299
Boardman 298
Nanchang 228
Los Angeles 188
Princeton 186
Lawrence 181
Wilmington 175
Munich 171
Shenyang 161
Changsha 150
Helsinki 140
Ann Arbor 137
Milan 128
New York 119
Jiaxing 118
Hebei 114
Medford 111
Moscow 111
Redondo Beach 108
Ho Chi Minh City 102
Tianjin 98
Buffalo 88
Turku 86
Hangzhou 84
Shanghai 84
Pavia 74
Woodbridge 66
Dearborn 62
Hanoi 53
São Paulo 49
Verona 41
Warsaw 41
Seattle 40
Nuremberg 38
Toronto 37
Norwalk 35
The Dalles 35
Houston 34
Brussels 33
Tokyo 33
Brooklyn 32
Denver 31
Rome 31
London 29
Santa Clara 29
Chicago 27
Falls Church 26
Kunming 25
San Francisco 25
Chennai 24
Falkenstein 24
Guangzhou 24
Frankfurt am Main 23
Phoenix 23
Boston 22
Orem 22
Rio de Janeiro 22
Montreal 21
Washington 20
Columbus 19
Johannesburg 19
Atlanta 18
Fairfield 18
Mexico City 18
Jinan 16
Mulazzano 16
Pune 16
Stockholm 16
Tappahannock 16
Chongqing 15
Curitiba 15
Piemonte 14
Piscataway 14
Vienna 14
Auburn Hills 13
Biên Hòa 13
Amsterdam 12
Brasília 12
Mumbai 12
Redwood City 12
Turin 12
Brno 11
Campinas 11
Council Bluffs 11
Des Moines 11
Guayaquil 11
Zhengzhou 11
Düsseldorf 10
Poplar 10
Secaucus 10
Ankara 9
Belo Horizonte 9
Totale 10.593
Nome #
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 131
Temporal trend in the prevalence of asthma-like symptoms among young adults of Northern Italy. Results of European Community Respiratory Health Survey (ECRHS) – ITALY 2000 131
Correction to: Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy (Internal and Emergency Medicine, (2020), 15, 8, (1457-1465), 10.1007/s11739-020-02493-y) 123
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 123
Asthma control in Europe: a real-world evaluation based on an international population-based study 119
Chronic cough and phlegm in young adults 119
Lyosecretome for use in the treatment of autoimmune diseases 119
Lyosecretome for use in the treatment or prevention of skin aging by inhibiting elastase and tyrosinase activity 117
Il test da sforzo cardiopolmonare (TCP) nello studio delle malattie respiratorie e in riabilitazione. Parte II. 115
Persistent exercise limitation after successful pulmonary endoarterectomy: frequency and determinants 115
Test di provocazione bronchiale con metacolina (TPBM). Riflessioni sulle linee guida ATS 1999 – confronti con le linee guida ERS 1993. 114
Bronchial responsiveness to ultrasonic fog in occupational asthma due to toluene diisocyanate 114
ADRB2 Gly16Arg polymorphism, asthma control and lung function decline. 114
Long-term effects of pulmonary andoarterectomy on cardioplmonary function and exercise tolerance 113
Allergen-specific immunoglobulin E and allergic rhinitis severity 113
The relationship between allergen immunotherapy and omalizumab for treating asthma 112
Lyosecretome for use in the treatment of degenerative osteoarticular diseases and/or degenerative intervertebral disc disease. 112
Advances in Identifying Urine/Serum Biomarkers in Alpha-1 Antitrypsin Deficiency for More Personalized Future Treatment Strategies 112
Aerosol thermal therapy benefit in chronic bronchitis treatment. 111
Allergic rhinitis and asthma comorbidity in a survey of young adults in Italy. 110
Assessment and management of pulmonary alveolar proteinosis in a reference center. 110
"Nonobstructive" emphysema of the lung 108
Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy 108
Athletic protocol in non-cystic fibrosis-related bronchiectasis: rationale and design of the pilot ATHOS study 106
Are the asthma guideline goals achieved in daily practice? A population-based study on treatment adequacy and the control of asthma 105
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy 104
Nutritional parameters associated with prognosis in non-critically ill hospitalized COVID-19 patients: The NUTRI-COVID19 study 104
Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome 102
Adipose Mesenchymal Extracellular Vesicles as Alpha-1-Antitrypsin Physiological Delivery Systems for Lung Regeneration 101
COVID vaccination and asthma exacerbation: might there be a link? 101
Changes in IgE sensitization and total IgE levels over 20 years of follow-up 100
Assessment of emphysema in COPD. A functional and radiologic study 99
Il rapporto VEMS/CVF come cut-off fisso é un parametro accurato e affidabile per la diagnosi funzionale di ostruzione bronchiale nella BPCO: CON | [FEV1/FVC as a fixed cut-off is an accurate and reliable parameter for functional diagnosis of bronchial obstruction in COPD: CON] 99
Long-term outcome after pulmonary endarterectomy. 98
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 98
Mechanisms for isolated volume response to a bronchodilator in patients with COPD 97
Asthmatics and ex-smokers respond early, heavy smokers respond late to mailed surveys in Italy. 97
Chronic productive cough in young adults is very often due to chronic rhino-sinusitis 95
Longterm hemodynamic and functional results after pulmonary endarterectomy 95
Pulmonary endarterectomy: the lancet first, tears for pills. 94
Lyosecretome for use in the treatment of alpha-1-antitrypsin deficiency associated diseases 94
An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages. 93
Linee guida per la misurazione ed interpretazione dei valori di ossigenazione arteriosa. 92
Lung bronchiectasisas a paradigm of the interplay between infection and colonization on plastic modulation of the pre-metastatic niche 90
Mesenchymal Extracellular Vesicles as Alpha-1-antitrypsin physiological delivery systems for lung regeneration 90
Exacerbations as a starting point of pro-active chronic obstructive pulmonary disease management. 88
Patients' interest in educational programmes on asthma. 87
Changes in the use of anti-asthmatic medication in an international cohort. 87
Asthma in childhood reduces smoking initiation in subsequent teenage among males. 87
A three-generation study on the association of tobacco smoking with asthma 87
Freeze-dried MSC-secretome contains active alpha-1-antitrypsin for treatment of deficiency pulmonary diseases 85
Lung function in survivors of childhood acute lymphoblastic leukemia 84
Quality-of-life and asthma-severity in general population asthmatics: results of the ECRHS II study 84
Late pulmonary sequelae after childhood bone marrow transplantation 84
The course of asthma during pregnancy in a recent, multicase-control study on respiratory health 84
Pulmonary involvement in patients with Marfan Syndrome. 83
Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital 83
Human health and air conditioning systems. 82
The role of climate on the geographic variability of asthma, allergic rhinitis and respiratory symptoms: results from the Italian study of asthma in young adults. 82
SORVEGLIANZA DELLE MALATTIE BRONCOPOLMONARI CRONICO-OSTRUTTIVE NELLA POPOLAZIONE DI ROVESCALA (PAVIA) IN RELAZIONE ALL’ ESPOSIZIONE AL FUMO DI TABACCO 82
Case-finding for alpha1-antitrypsin deficiency in Kazakh patients with COPD 82
Pharmacological treatment of asthma in a cohort of adults during a 20-year period: results from the European Community Respiratory Health Survey I, II and III 82
Effects of inhaled steroids on methacholine-induced bronchoconstriction and gas trapping in mild asthma. 81
Underestimation of airflow obstruction among young adults using FEV1/FVC <70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes. 81
Occupational asthma caused by milk proteins: report on a case. 80
Prevalence of allergic rhinitis in young adults in Italy 80
The socio-economic burden of asthma is substantial in Europe. 80
The Impact of Diagnosed and Undiagnosed Current Asthma in the General Adult Population 80
The Rapid FEV(1) Decline in Chronic Obstructive Pulmonary Disease Is Associated with Predominant Emphysema: A Longitudinal Study. 80
Absolute values of lung function explain the sex difference in breathlessness in the general population 80
Asthma-like symptoms: Is it always a pulmonary issue? 80
Assessment of asthma severity in adults with ever asthma: A continuous score 79
Asthma Severity According to Global Initiative for Asthma and Its Determinants:An International Study. 78
Lung cancer resection: the prediction of postsurgical outcomes should include long-term functional results. 77
Freeze-dried MSC-secretome for use in the treatment of alpha-1-antitrypsin deficiency pulmonary diseases 77
Antihistamines in children and adolescents: A practical update 77
Eosinophilic cationic protein (ECP) in the clinical work-up of chronic cough 76
Atmosphere pollutants 76
Variations in the prevalence across countries of chronic bronchitis and smoking habits in young adults 76
Il test da sforzo cardiopolmonare (TCP) nello studio delle malattie respiratorie e in riabilitazione. Parte I. 76
Long-term outcomes of pulmonary endarterectomy (PEA) for chronic thromboembolic pulmonary hypertension (CTEPH) 76
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey 76
MSC extracellular vesicles for treatment of alpha-1-antitrypsin deficiency pulmonary diseases 76
International variations in asthma treatment compliance: the results of the European Community Respiratory Health Survey (ECRHS). 75
Long-term clinical and cardiopulmonary effects of pulmonary endarteriectomy (PEA) 75
Incidence of COPD in a Cohort of Young Adults According to the Presence of Chronic Cough and Phlegm. 75
Pulmonary arterial compliance and exercise capacity after pulmonary endarterectomy. 74
COPD classification methods and informativeness on mortality: contrasting evidences. 74
Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD 74
Impact of asthma and comorbid allergic rhinitis on quality of life and control in patients of Italian general practitioners. 73
Inadequate antiasthma drug use in the north of Italy. 73
Protein expression in sputum of smokers and chronic obstructive pulmonary disease patients: a pilot study by CapLC-ESI-Q-TOF. 73
Paediatric Oncology and Bone Marrow Transplantation. 72
Prevalence of asthma-like symptoms with ageing 72
Eosinophilic cationic protein (ECP) in the clinical work-up of chronic cough 71
Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis. 71
RESPIRATORY SYMPTOMS AND PULMONARY FUNCTION IN THE POPULATION OF PARONA (PV) ACCORDING TO TOBACCO EXPOSURE 71
Bioequivalence of inhaled formoterol fumarate assessed from pharmacodynamic, safety and urinary pharmacokinetic data. 70
Valutazione preoperatoria in chirurgia toracica. 70
Allergen-specific immunoglobulin E and allergic rhinitis severity 70
Totale 9.125
Categoria #
all - tutte 75.754
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.754


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021684 0 0 0 0 21 127 14 184 32 149 129 28
2021/2022796 10 19 23 7 26 33 34 41 55 23 137 388
2022/20232.791 341 144 27 278 230 284 7 180 1.151 21 82 46
2023/20241.079 118 203 47 65 118 238 51 85 10 48 30 66
2024/20253.719 70 223 102 149 94 322 186 238 867 194 397 877
2025/20264.141 654 690 993 1.196 608 0 0 0 0 0 0 0
Totale 16.906